TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20564923

Group type: EXPERIMENTAL
Intervention: Levosimendan and ivabradine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 41
Study: 18982536

Group type: EXPERIMENTAL
Intervention: Medium-nicotine cigarettes (0.6 mg nicotine)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low/zero-nicotine cigarettes (0.05 mg nicotine)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Secondhand smoke (medium-nicotine)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Secondhand smoke (low/zero-nicotine)
Number of subjects: 32
Study: 16567056

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) advertising
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Zyban advertising
Number of subjects: 718

Group type: COMPARATOR
Intervention: Non-pharmaceutical cessation services (Quitline) ads
Number of subjects: 718

Group type: COMPARATOR
Intervention: Non-cessation messages on sun protection
Number of subjects: 718
Study: 12727094

Group type: EXPERIMENTAL
Intervention: Portfolio assessment
Number of subjects: 12
Study: 11292003

Group type: EXPERIMENTAL
Intervention: 8 mg buprenorphine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 16 mg buprenorphine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9425409

Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lid taping (Control)
Number of subjects: 30
Study: 8084247

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg endovenously every 4 h for the first 12 h and every 6 h for the next 12 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nalbuphine 20 mg endovenously every 4 h for the first 12 h and every 6 h for the next 12 h
Number of subjects: 0
Study: 3664109

Group type: EXPERIMENTAL
Intervention: Female friend as co-therapist
Number of subjects: 30

Group type: COMPARATOR
Intervention: Husband as co-therapist
Number of subjects: 30

Group type: COMPARATOR
Intervention: Husband's depression at 2 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Overall effect of husband's depression
Number of subjects: 30
Study: 31342247

Group type: EXPERIMENTAL
Intervention: Ureteral access sheath (UAS) used for stone treatment (group-1)
Number of subjects: 338

Group type: COMPARATOR
Intervention: No ureteral access sheath used (group-2)
Number of subjects: 338
Study: 30709839

Group type: EXPERIMENTAL
Intervention: 10 g/day ground flaxseed for 6 weeks
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 252
Study: 28628622

Group type: EXPERIMENTAL
Intervention: Probiotic therapy
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Urinary tract infection (UTI) status
Number of subjects: 3
Study: 25733649

Group type: EXPERIMENTAL
Intervention: Ready-to-use, lipid-based supplementary food (RUSF)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Special corn-soy blend (CSB++)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Locally processed, fortified flour (Misola)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Locally milled flours plus oil, sugar, and micronutrient powder (LMF)
Number of subjects: 1264
Study: 23835431

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (16-week session)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (placebo or non-exercise)
Number of subjects: 45
Study: 21720788

Group type: EXPERIMENTAL
Intervention: P and E2 (4 mg/d)
Number of subjects: 118

Group type: COMPARATOR
Intervention: P
Number of subjects: 118
Study: 19939249

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including counselling sessions, courses, and informational packages for 7 months
Number of subjects: 163
Study: 16805685

Group type: EXPERIMENTAL
Intervention: Ultrasonic treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment at 160 mJ/pulse at 10 Hz
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 30
Study: 15012723

Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: basiliximab
Number of subjects: 28
Study: 10694836

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 747

Group type: COMPARATOR
Intervention: Nifedipine retard
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 747
Study: 8970278

Group type: EXPERIMENTAL
Intervention: 10-week behavioral medicine support group intervention
Number of subjects: 0
Study: 1457626

Group type: EXPERIMENTAL
Intervention: Melatonin (8 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6500760

Group type: EXPERIMENTAL
Intervention: Mepindolol 10 mg at 8 a.m.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mepindolol 10 mg at 8 p.m.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (during wash-out period)
Number of subjects: 0
Study: 31010875

Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg once-weekly
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 30033542

Group type: EXPERIMENTAL
Intervention: Doxycycline oral capsules 40 mg (DFD-09) under fed conditions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Doxycycline oral capsules 40 mg (DFD-09) under fasting conditions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Doxycycline oral capsules 40 mg (DFD-09)
Number of subjects: 12
Study: 27378239

Group type: EXPERIMENTAL
Intervention: Annual follow-up of nonsolid nodules (NSNs) identified by CT screening for lung cancer.
Number of subjects: 2534
Study: 24937223

Group type: EXPERIMENTAL
Intervention: Ceramic water filters (CWFs) impregnated with silver nanoparticles
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group without filters
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ceramic water filters (CWFs)
Number of subjects: 74
Study: 23101545

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19954772

Group type: EXPERIMENTAL
Intervention: Safety behavior reduction plus exposure (SB + EXP)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Graduated exposure (EXP)
Number of subjects: 130
Study: 17407214

Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 201
Study: 15887252

Group type: EXPERIMENTAL
Intervention: Exposure to RF fields emitted by mobile phones
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control session (no exposure to RFs)
Number of subjects: 0
Study: 12411221

Group type: EXPERIMENTAL
Intervention: Transdermal selegiline (20 mg applied once daily by means of a 20-cm² patch)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Transdermal selegiline
Number of subjects: 177
Study: 10449891

Group type: EXPERIMENTAL
Intervention: Valsartan in combination with ACE inhibitors and other prescribed therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 0
Study: 9275755

Group type: EXPERIMENTAL
Intervention: Essential Hypertensives (EH)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Normotensive Offspring from Hypertensive Families (SH)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Normotensive Controls
Number of subjects: 154

Group type: COMPARATOR
Intervention: Normotensive Families (SN)
Number of subjects: 154
Study: 2048958

Group type: EXPERIMENTAL
Intervention: Specific prevention interventions (mean number of 7.5 actions)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Classic surveillance (mean number of 1 action)
Number of subjects: 161
Study: 6758224

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Fansidar (two-tablet regimen)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Fansidar (three-tablet regimen)
Number of subjects: 104
Study: 31948992

Group type: EXPERIMENTAL
Intervention: Lymphaticovenous anastomosis (LVA) operation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 120
Study: 31274778

Group type: COMPARATOR
Intervention: Standard care (bordered polyurethane dressing, with prolene sutures, chlorhexidine gluconate disc)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Integrated dressing securement (SorbaView SHIELD, with prolene sutures and chlorhexidine gluconate disc)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Tissue adhesive (Histoacryl, B Braun) in addition to standard care
Number of subjects: 180
Study: 27817915

Group type: EXPERIMENTAL
Intervention: Evicel fibrin glue
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Tisseel fibrin glue
Number of subjects: 89

Group type: COMPARATOR
Intervention: 10-0 Vicryl sutures
Number of subjects: 89
Study: 26212172

Group type: EXPERIMENTAL
Intervention: CoQ10 plus NADH supplementation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 24462073

Group type: EXPERIMENTAL
Intervention: High-dose statins (atorvastatin 80 mg or rosuvastatin 20 mg)
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Low-dose statins or no statins
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: High-dose statins (after propensity score adjustment)
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Low-dose statins or no statins (after propensity score adjustment)
Number of subjects: 1528
Study: 23152589

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 19574017

Group type: EXPERIMENTAL
Intervention: Active TEAS (transcutaneous electric acupoint stimulation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Active TEAS
Number of subjects: 48
Study: 17852631

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (betamethasone-dipropionate cream)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 14
Study: 16265633

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Patients with hepatic encephalopathy (HE)
Number of subjects: 11
Study: 12100779

Group type: EXPERIMENTAL
Intervention: 2 health screenings
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: 2 health screenings + 45-minute follow-up consultation annually
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group (no health screenings)
Number of subjects: 2000
Study: 10417250

Group type: EXPERIMENTAL
Intervention: Word processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Object processing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Words and objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naming words and objects
Number of subjects: 0
Study: 7502226

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy (platinum-based combination chemotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: External beam radiotherapy
Number of subjects: 0
Study: 2278549

Group type: EXPERIMENTAL
Intervention: Ayurvedic drug treatments for three months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 7003032

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Amantadine (200 mg/day)
Number of subjects: 555
Study: 31122045

Group type: EXPERIMENTAL
Intervention: Prevention of mother-to-child transmission of HIV intervention
Number of subjects: 1399

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1399
Study: 28276148

Group type: EXPERIMENTAL
Intervention: Follicle flushing three times with 2 ml in each follicle
Number of subjects: 80

Group type: COMPARATOR
Intervention: Direct follicle aspiration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Follicle flushing
Number of subjects: 80
Study: 24841733

Group type: EXPERIMENTAL
Intervention: Intralesional tetracycline 2% injection
Number of subjects: 11
Study: 23238443

Group type: EXPERIMENTAL
Intervention: Rigid contact lens correction
Number of subjects: 500
Study: 21325345

Group type: EXPERIMENTAL
Intervention: Pravastatin (2891 participants)
Number of subjects: 5804

Group type: COMPARATOR
Intervention: Placebo (2913 participants)
Number of subjects: 5804
Study: 18752466

Group type: EXPERIMENTAL
Intervention: Single session of evening exercise (1 hour at 60% of VO2 peak)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Evening rest (control)
Number of subjects: 8
Study: 17196795

Group type: EXPERIMENTAL
Intervention: SSRIs with hormonal therapy (HT)
Number of subjects: 170

Group type: COMPARATOR
Intervention: SSRIs without hormonal therapy (HT)
Number of subjects: 170
Study: 15505441

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 6

Group type: COMPARATOR
Intervention: Natural Sleep
Number of subjects: 6
Study: 11227936

Group type: EXPERIMENTAL
Intervention: Rectal pressure-volume measurement with a compliant balloon
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rectal impedance planimetry
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pressure-volume measurement with a large, noncompliant bag
Number of subjects: 10
Study: 9781630

Group type: EXPERIMENTAL
Intervention: ACTH infusion (0.25 mg Cosyntropin intravenously over 240 minutes) after hypoglycemic insulin clamp (1 mU/kg/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: ACTH infusion (0.25 mg Cosyntropin intravenously over 240 minutes) after euglycemic clamp
Number of subjects: 10
Study: 7811440

Group type: EXPERIMENTAL
Intervention: Alcohol reduction intervention (cognitive-behavioral program with six counseling sessions over 3 months)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Control observation group
Number of subjects: 580
Study: 2193774

Group type: EXPERIMENTAL
Intervention: Anodyne-lubricant jelly (ALJ)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo 1 (ALJ and placebo)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo 2 (lidocaine and placebo)
Number of subjects: 372
Study: 353973

Group type: EXPERIMENTAL
Intervention: Cimetidine (26 patients)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (29 patients)
Number of subjects: 55
Study: 30526281

Group type: EXPERIMENTAL
Intervention: Antithrombotic drug use (either antiplatelets or anticoagulants)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Delay in surgery after cessation of antiplatelet drug
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Early surgery and early antithrombotic recommencement
Number of subjects: 817
Study: 30531381

Group type: EXPERIMENTAL
Intervention: Integrated dual-task training
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Consecutive dual-task training
Number of subjects: 121
Study: 28624294

Group type: EXPERIMENTAL
Intervention: Patient decision aid plus surgeon preference report (decision aid)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 343
Study: 26165370

Group type: EXPERIMENTAL
Intervention: Tuina techniques applied to real acupoints
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-specific skin points treatment (Control)
Number of subjects: 69
Study: 23844552

Group type: EXPERIMENTAL
Intervention: Brief counselling session on alcohol risk reduction
Number of subjects: 392

Group type: COMPARATOR
Intervention: Health education leaflet
Number of subjects: 392
Study: 21999717

Group type: EXPERIMENTAL
Intervention: Telephone care management intervention
Number of subjects: 499

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 499
Study: 19651998

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 17214754

Group type: EXPERIMENTAL
Intervention: Range-of-motion exercise programme (4-week, twice-per-day, 6 days-per-week) supervised by a Registered Nurse
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Range-of-motion exercise programme (4-week, twice-per-day, 6 days-per-week) with physical assistance from a Registered Nurse
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study: 14667431

Group type: EXPERIMENTAL
Intervention: Brief stage‐matched interventions
Number of subjects: 4653

Group type: EXPERIMENTAL
Intervention: Interventions helping populations progress two stages
Number of subjects: 4653
Study: 11704162

Group type: EXPERIMENTAL
Intervention: Venlafaxine (50-200 mg/day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 9791141

Group type: EXPERIMENTAL
Intervention: Triple-drug therapy (indinavir, zidovudine, lamivudine)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Indinavir alone
Number of subjects: 316

Group type: COMPARATOR
Intervention: Zidovudine and lamivudine
Number of subjects: 316
Study: 8162724

Group type: EXPERIMENTAL
Intervention: Nasal BiPAP
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham BiPAP
Number of subjects: 9
Study: 2756516

Group type: EXPERIMENTAL
Intervention: Nifuroxazide 400 mg twice a day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifuroxazide 1200 mg once a day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31216092

Group type: EXPERIMENTAL
Intervention: Quantitative structure‐retention relationship models for phthalic acid esters
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Predictive models for retention times of new phthalic acid esters
Number of subjects: 23
Study: 28160873

Group type: EXPERIMENTAL
Intervention: Abaloparatide (ABL-SC) followed by Alendronate (ALN)
Number of subjects: 1139
Study: 26008722

Group type: EXPERIMENTAL
Intervention: T2DM-high VF
Number of subjects: 151

Group type: COMPARATOR
Intervention: NGT-high VF
Number of subjects: 151

Group type: COMPARATOR
Intervention: NGT-normal VF
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: T2DM-normal VF
Number of subjects: 151
Study: 23409290

Group type: EXPERIMENTAL
Intervention: Family Spirit intervention plus optimized standard care
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Family Spirit intervention
Number of subjects: 322

Group type: COMPARATOR
Intervention: Optimized standard care alone
Number of subjects: 322
Study: 22111822

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment using a 4-day dietary recall
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment
Number of subjects: 291
Study: 18996523

Group type: EXPERIMENTAL
Intervention: ABT-335 + rosuvastatin 10 mg
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: ABT-335 + rosuvastatin 20 mg
Number of subjects: 1445
Study: 17026664

Group type: EXPERIMENTAL
Intervention: Antioxidant preparation applied to forearm skin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control area (no antioxidant preparation)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison with DermAnalyzer method
Number of subjects: 15
Study: 15576014

Group type: EXPERIMENTAL
Intervention: Sustained-release lithium carbonate matrix tablets containing 450 mg LC with 15% CP
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sustained-release commercial tablet (Eskalith CR)
Number of subjects: 9
Study: 11094787

Group type: EXPERIMENTAL
Intervention: 5 mg/m3 zinc oxide inhalation for naive subjects on 1 or 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc oxide inhalation for sheet metal workers on 1 day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control furnace gas inhalation for sheet metal workers on another day
Number of subjects: 0
Study: 9125668

Group type: EXPERIMENTAL
Intervention: Diltiazem extended-release 240 mg once daily for 8 weeks
Number of subjects: 30
Study: 8385161

Group type: EXPERIMENTAL
Intervention: OPC-21268 10 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: OPC-21268 50 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: OPC-21268 300 mg, 3 times daily for 7 days
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: OPC-21268 100 mg single doses
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 3898834

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination therapy (Sucralfate + Cimetidine)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 61
Study: 31240854

Group type: EXPERIMENTAL
Intervention: PlGF testing alongside a clinical management algorithm
Number of subjects: 11

Group type: COMPARATOR
Intervention: Current standard care
Number of subjects: 11
Study: 30129537

Group type: EXPERIMENTAL
Intervention: Right lateral position
Number of subjects: 63

Group type: COMPARATOR
Intervention: Left lateral position
Number of subjects: 63

Group type: COMPARATOR
Intervention: All positions
Number of subjects: 63
Study: 27510395

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg over 10 minutes followed by a 0.5 μg/kg/hr infusion)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fentanyl (1.0 μg/kg over 1 minute followed by a 0.4 μg/kg/hr infusion)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Remifentanil (1.0 μg/kg over 1 minute followed by a 0.08 μg/kg/min infusion)
Number of subjects: 90
Study: 25088285

Group type: EXPERIMENTAL
Intervention: Complicated grief (CG)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 335
Study: 21127953

Group type: COMPARATOR
Intervention: Better mother-child interactions (measured by mother's responsiveness)
Number of subjects: 432
Study: 20033417

Group type: EXPERIMENTAL
Intervention: Organically produced apples (1 kg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Conventionally produced apples (1 kg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Organically produced apples (500 g/day for 4 weeks)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Conventionally produced apples (500 g/day for 4 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no apples)
Number of subjects: 49
Study: 18525384

Group type: EXPERIMENTAL
Intervention: 6 g of green tea
Number of subjects: 14

Group type: COMPARATOR
Intervention: 125 mg of caffeine
Number of subjects: 14

Group type: COMPARATOR
Intervention: hot water
Number of subjects: 14
Study: 15994660

Group type: EXPERIMENTAL
Intervention: Locality based community hospital care
Number of subjects: 220

Group type: COMPARATOR
Intervention: Care on a ward for elderly people in a district general hospital
Number of subjects: 220